Consequently, increasing the activity of phase II enzymes, such as glutathione S-transferases (GSTs) and NQO-1, may help prevent cancer by enhancing the elimination of potential carcinogens (see the Nrf2-dependent antioxidant pathway) (63)
doi: 10.3390/children4080066 157
Forum protocols and influencer threads supply the demand, podcasts supply the reach, and an affiliate link supplies the incentive to keep the story simple and bright
Summary: GLP-1/GIP medications help reduce inflammation in metabolic organsnot autoimmune or pain-related inflammation They DO: lower CRP and related metabolic inflammatory/oxidative stress biomarkers, improve metabolic liver disease activity in steatohepatitis settings, improve cardiometabolic risk markers such as blood pressure improve kidney outcomes in high-risk CKD populations (semaglutide
Park CK, Go EJ, Jo H, Hwang SM, Rahman MM, Park J, Lee JY, Jo YY, Jung Y, Berta T, Kim YH (2024) GLP-1 and its derived peptides mediate Pain Relief through Direct TRPV1 inhibition without affecting Thermoregulation
.jpg)
